US Supreme Court Restores Mail Access to Abortion Pill Mifepristone

The US Supreme Court has issued an emergency order restoring access to the abortion pill mifepristone via mail, temporarily blocking restrictions imposed by a lower court. This ruling allows the medication to remain available through telemedicine and postal delivery while ongoing litigation proceeds, a process that could extend into next year. The decision follows a lawsuit filed by the state of Louisiana against the Food and Drug Administration (FDA), which had permanently authorized mail-order distribution in 2023. Louisiana argued that nationwide postage of the drug undermined its state-level abortion ban. Two manufacturers of mifepristone petitioned the Supreme Court to intervene after an appeals court reinstated in-person dispensing requirements. The Supreme Court's stay was issued without detailed reasoning. Justices Clarence Thomas and Samuel Alito dissented, with Justice Thomas characterizing the mail distribution as illegal in Louisiana and dismissing the manufacturers' claims based on lost profits from what he termed a criminal enterprise. Mifepristone remains the most common method for terminating pregnancies in the United States, particularly in states where surgical abortion is banned or heavily restricted following the overturning of Roe v. Wade.